Page 149 - MemoriaBBN-Eng

www.ciber-bbn.es

• s t, s-v s, d l, G t mi, G md, J mi .. The
Most relevant AinzerrAnoillAríAzonzálezoméurBindode oséet Al
CD4/CD8 ratio as a marker T-cell activation, senescence and activation/exhaustion
scientific in treated HIV-infected children and young adults.AIDS. 2013 Jun 1;27(9):1513-6.

articles
• CórdoBA ev, Pion m, rAsines B, FiliPPini d, KomBer h, ionov m et Al.. Glycodendrimers as
new tools in the search for effective anti-HIV DC-based immunotherapies.Nanome-

dicine. 2013 Oct;9(7):972-84.

• CórdoBA ev, Arnáiz e, de lA mAtA FJ, Gómez r, leAl m, Pion m et Al.. Synergistic activity
of carbosilane dendrimers in combination with maraviroc against HIV in vitro.AIDS.

2013 Aug 24;27(13):2053-8.

• vACAs CórdoBA e, ArnAiz e, relloso m, sánChez-torres C, GArCíA F, Pérez-álvArez l et
.. Development of sulphated and naphthylsulphonated carbosilane dendrimers
Al
as topical microbicides to prevent HIV-1 sexual transmission. AIDS. 2013 May
15;27(8):1219-29.
ó
• s-C d, l r, l m, G r, d m FJ, J Jl .. Syner-
ePúlvedAresPoorenteeAlómezelA AtAiménezet Aló
gistic activity profile of carbosilane dendrimer G2-STE16 in combination with other

dendrimers and antiretrovirals as topical anti-HIV-1 microbicide.Nanomedicine.;.

The group has obtained funding to develop the proyects: EU-Belarus-Russia Network in
Highlights
í
Nanomaterials-Driven Anti-Cancer Gene Therapy. NANOGENE. SEVENTH FRAMEWORK
PROGRAMME. Cooperation Work Programme: Health-2010. ERA-Net EuroNanoMedicine

Identification: 316730 / PIRSES-GA-2012-316730. Proyect: Desarrollo y mecanismo de
accin de dendrmeros como microbicidas para frenar la infección por VIH por transmi- ó

sin sexual (vaginal y anal): prueba de concepto (FIS PI13/02016), from RED TEMÁTI-
CA Iberoamericano de Ciencia y Tecnología para el Desarrollo (CYTED): Desarrollo de

una vacuna frente a VIH: estudio de los cambios en la biología de células dendríticas
humanas tras interaccin con distintos sistema de liberación de péptidos de VIH (VI-

HVACD) (participate Chile, Argentina, Perú, Mexico, Portugal, Spain), also take part
in SUBPROGRAMA RETICS (Redes Temáticas de Investigación Cooperativa en Salud).

Identification: RD 12/0017/0037; and Redes Moleculares y Celulares en Enfermedades
Inflamatorias proyect: INDISNET.Identification: S2010/BMD-2332

Molecular Immunobiology group develops the Coordination and Direction of HIV-HGM

BioBank and its Reposity associated. HIV-HGM BioBank criopreserves very valuable
collections in several pathologies as HIV, cancer, rare illness, respiratory, endocrine and

infectious diseases.

RESEARCH PUBLICATIONS & H FACTOR
• 2013: 33 Articles in 1st Decilee/Quartile–2013 IF: 4,174– Accumulated IF: 4,364.

•Totalarticles:186Articlesin1stDecilee/Quartile –Accumulated1994-2014IF:4,740

• IP H factor: 29

RESEARCH PROYECTS

• 2013 : 11 National & International Research Proyects as IP or Coordinator 13
20
• 4 National & International Research Proyects as collaborator T
• Total proyects: 46 National & International Research Proyects as IP or Coordinator OR
P
• 22 National & International Research Proyects as collaborator RE
L
DIRECTED DOCTORAL THESIS A
NU
• 2014: 4 National & International doctoral thesis N
A
• Total thesis: 39 National & International doctoral thesis N /
B
PATENTS & SPIN OFFS -B
• 14 patents or utility models as applicant or inventor. R
BE
PCT/ES2013/0705 ADMITED IN 2013
CI

• 2 start ups (GENOMADRID SL, DendriCo SL) & 1 spin off (Ambiox Biotech SL) in active 149

2013.